An observational study in Neurodevelopmental Motor Disorders, sponsored by Centre Hospitalier Universitaire Dijon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-22.
Sponsored by Centre Hospitalier Universitaire Dijon · Observational
The PRéPaR project aims to construct, with the help of parents and early care providers, a support program for the families of infants at an increased risk for neurodevelopmental disorders, and to evaluate the acceptability and feasibility of such a program. This program aims to strengthen parenting skills, support infant development and improve the continuity of hospital/non-hospital care, including early identification of neurodevelopmental motor disorders and continuation of the support initiated during neonatal hospitalization.
78 studies on the registry are indexed under Motor Disorders; 26 are open to participants now.
This study's planned enrollment of 88 is above the median of 70 across 23 observational studies indexed under Motor Disorders.
Browse Motor Disorders studies →Centre Hospitalier Universitaire Dijon is the lead sponsor of 495 studies on the registry; 105 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Parents of infants at high risk of neurodevelopmental disorders Parents of children with developmental disorders
WP1:
For the group of parents of children with documented neurodevelopmental difficulties, their child must meet the following three conditions:
Have at least one risk factor putting them at high neurodevelopmental risk at birth:
The parents must be able to participate in the 3 interviews (T1, T2 and T3).
For the group of infants at high neurodevelopmental risk at hospital discharge, their child must meet the following two conditions:
Have at least one risk factor putting them at high neurodevelopmental risk at birth:
The parents must be able to participate in the 3 interviews (T1, T2 and T3).
Physiotherapists in private practice, labor and delivery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and doctors involved in the care of children at developmental risk in charge of the follow-up of children for whom the parents have agreed to participate in the study. These professionals must in turn have agreed to participate in the study. User representatives (SOS Préma, Le Neurogroup...) who have agreed to participate in the study.
WP2:
Parents of children hospitalized in the neonatal services of the CHU Dijon who meet at least one of the following criteria:
Have at least one risk factor putting them at high neurodevelopmental risk at birth:
Physiotherapists in private practice, labor and delievery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and physicians involved in the care of children at developmental risk in charge of the follow-up of the children whose parents agreed to participate in the study. These professionals must in turn have agreed to participate in the study.
Exclusion Criteria:
Group representatives (SOS Préma, The Neurogroup...)
Other: Focus group (FC) - WP1
infants between 34 weeks' gestation and 4 months' corrected age at the time of the first focus group and with at least one risk factor for neurodevelopmental disorder
Other: Focus group (FC) - WP1
children between 18 and 48 months corrected age at the time of the first focus group: * with at least one risk factor for neurodevelopmental disorder * presenting an abnormal, non-transient clinical state
Other: Focus group (FC) - WP1
Private physiotherapists, labor and delivery nurses of the Maternal and Child Protection, Centre d'action médico-sociale précoce (CAMSP) (psychomotricians, psychologists) and doctors involved in the care and follow up of children at risk of developmental disorders whose parents have agreed to participate in the study.
Other: Focus group (FC) - WP1
Physiotherapists working in a private practice
Other: Child Neurodevelopment Questionnaires - WP2 · Other: Evaluation of compliance for the acquired skills in terms of development support - WP2 · Other: Evaluation of physiotherapist satisfaction with the follow-up and the time spent at the consultation - WP2 · Other: 4 Focus Group (FC) - WP2
parents of hospitalized children between 34 weeks of gestation and 4 months of corrected age with at least one risk factor for neurodevelopmental disorder
Other: 4 Focus Group (FC) - WP2
Labor and delivery nurses from the Protection Maternelle et Infantile, CAMPS (psychomotricians, psychologists) and doctors involved in the care of children at risk of developmental disorders who are in charge of the follow-up of children whose parents have agreed to participate in the study.
Other: 4 Focus Group (FC) - WP2
3 group meetings for each group of parents: 1. Parents only 2. Parents and representatives of patient support groups 3. Parents and health professionals specialized in the care of these children at risk
during the 4th month of corrected infant age
during the 4th month of corrected infant age
at the end of the study
* Parents who accepted the follow-up * Parents who have partially completed the programme * Maternal and Child Protection \& CAMSP professionals * Physiotherapists in a private practice
Typology, categorization and operationalization of parental needs and expectations
These will be used to develop of the early education program
Time frame: Through WP1 completion an average of 18 months
Typology of perceived subjective representations and description of barriers and levers to use with parents and professionals
Time frame: through WP2 completion an average of 16 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire Dijon